This is a medico-economic study of outpatient surgery paired with a night stay in a patient-hotel, compared with a conventional hospitalization for three types of urological surgeries. The aim is to show that those two strategies are not different in term of adverse effects or rehospitalization, and that the patient-hotel provide a better quality of life at a reduced cost, in order to generate savings for the paying agent: the Healthcare insurance.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Enrollment
10
Outpatient surgery First night stay in a defined patient-hotel Patient come for consultation the next morning of surgery to remove the catheter and/or the compressive bandage. The absence of adverse events is checked, the discharge is confirmed and the evaluation questionnaire is given to the patient. Postoperative consultation at 1 and 3 months.
Hospitalization for surgery and first postoperative night stay. Postoperative consultation at 1 and 3 months
Service d'Urologie du Centre Hospitalier Lyon Sud, Hospices Civils de Lyon
Pierre-Bénite, France
ICER = Incremental Cost-Effectiveness Ratio of Costs and QALY(quality-adjusted life year) (unit of measure = cost(€)/QALY)
Efficacity (QALY) is a composite measure of quality of life and adverse events occurence: * Quality of life is a composite score of : EQS5D questionnaire converted in utility, Other questionnaires : SF-12 ; International Continence Society short form, Post-Operative Patient, Global Impression of Improvement (PGI-I), l'Incontinence Impact Questionnaire-Short Form (IIQ-SF) et l'Urogenital Distress Index (UDI-SF). * Adverse events occurrence : urinary retention, postoperative infection, rehospitalization Costs : according to " micro-costing " method. Rehospitalizations will be priced from ENC rate.
Time frame: at 3 months
postoperative complications
All postoperative complications that occur within 3 months
Time frame: at 3 months
Change in general quality of life postoperatively measured by EQ5D questionnaire
Time frame: at Baseline and after surgery at day one
Change in general quality of life postoperatively measured by SF12 questionnaire
Time frame: at Baseline and after surgery at day one
Change in general quality of life at 3 months after surgery measured by EQ5D questionnaire
Time frame: at Baseline and at 3 moths
Change in general quality of life at 3 months after surgery measured by SF12 questionnaire
Time frame: at Baseline and at 3 moths
Change in specific quality of life measured by questionnaires International Continence Society short form
Time frame: at Baseline and after surgery at day one
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Change in specific quality of life measured by Post-Operative Patient questionnaire
Time frame: at Baseline and after surgery at day one
Change in specific quality of life measured by Global Impression of Improvement (PGI-I) questionnaire
Time frame: at Baseline and after surgery at day one
Change in specific quality of life measured by Incontinence Impact Questionnaire-Short Form (IIQ-SF)
Time frame: at Baseline and after surgery at day one
Change in specific quality of life measured by Urogenital Distress Index (UDI-SF) questionnaire
Time frame: at Baseline and after surgery at day one
Change in specific quality of life measured by International Continence Society short form
Time frame: at Baseline and at 3 months
Change in specific quality of life measured by Post-Operative Patient questionnaire
Time frame: at Baseline and at 3 months
Change in specific quality of life measured by Global Impression of Improvement (PGI-I) questionnaire
Time frame: at Baseline and at 3 months
Change in specific quality of life measured by Incontinence Impact Questionnaire-Short Form (IIQ-SF)
Time frame: at Baseline and at 3 months
Change in specific quality of life measured by Urogenital Distress Index (UDI-SF) questionnaire
Time frame: at Baseline and at 3 months